Рет қаралды 394
Dr. Maureen Mayes is the keynote speaker and presents at the Scleroderma Foundation Texas Bluebonnet Chapter's Scleroderma Education Day Webinar on February 27, 2021. Dr. Mayes brings us up to date on Scleroderma Clinical Trials, both current and future.
Maureen Mayes, MD, MPH bio:
- Scleroderma Foundation’s 2020 Lifetime Achievement Award. The Lifetime Achievement Award is the Foundation’s highest honor and is reserved for individuals to the Scleroderma Foundation for at least a decade across its entire scope of mission.
- Scleroderma Foundation’s Messenger of Hope Award
- Scleroderma Foundation Medical & Scientific Advisory Board for 22 years
- Founder of the Scleroderma Clinical and Research Program at McGovern Medical School
- Author of “The Scleroderma Book: A Guide for Patients and Families.
- Published over 250 articles and reviews in the medical literature describing her research findings
- Current research is focused on the identification of genetic susceptibility factors and the establishment of scleroderma biomarkers for prognostic and predictive value to determine a more targeted therapeutic approach.
Scleroderma Foundation Texas Bluebonnet Chapter
Website: www.scleroderma.org/texas
Email: txchapter@scleroderma.org
Facebook: sclerotxchapter
Twitter: @sclerotxchapter
Instagram: @scleroderma_txchapter